Join
Live feed
·
PRReleasevia Quantisnow
Metagenomi Therapeutics Inc. logo
Cellectis S.A. logo

Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
MGX· Metagenomi Therapeutics Inc.CLLS· Cellectis S.A.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MGX (Metagenomi Therapeutics Inc.), CLLS (Cellectis S.A.) and more on Quantisnow.